BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevaliez S. Strategies for the improvement of HCV testing and diagnosis. Expert Rev Anti Infect Ther 2019;17:341-7. [PMID: 30950298 DOI: 10.1080/14787210.2019.1604221] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Martínez I, Ryan P, Valencia J, Resino S. The Challenging Road to Hepatitis C Virus Eradication. J Clin Med 2021;10:611. [PMID: 33562818 DOI: 10.3390/jcm10040611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Pyziak-Kowalska KA, Horban A, Bielecki M, Kowalska J. Missed opportunities for diagnosing viral hepatitis C in Poland. Results from routine HCV testing at the Emergency Department in the Hospital for Infectious Diseases in Warsaw. Clin Exp Hepatol 2019;5:294-300. [PMID: 31893241 DOI: 10.5114/ceh.2019.89148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Huang CF, Wu PF, Yeh ML, Huang CI, Liang PC, Hsu CT, Hsu PY, Liu HY, Huang YC, Lin ZY, Chen SC, Huang JF, Dai CY, Chuang WL, Yu ML. Scaling up the in-hospital hepatitis C virus care cascade in Taiwan. Clin Mol Hepatol 2021;27:136-43. [PMID: 33317253 DOI: 10.3350/cmh.2020.0150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ryan P, Valencia J, Cuevas G, Troya J, Torres-Macho J, Muñoz-Gómez MJ, Muñoz-Rivas N, Canorea I, Vázquez-Morón S, Resino S. HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study. Infect Dis Poverty 2021;10:111. [PMID: 34412695 DOI: 10.1186/s40249-021-00894-5] [Reference Citation Analysis]
5 Mari PC, Gulati R, Fragassi P. Adolescent Hepatitis C: Prevalence, Impact, and Management Challenges. Adolesc Health Med Ther 2021;12:45-53. [PMID: 33994820 DOI: 10.2147/AHMT.S263864] [Reference Citation Analysis]
6 Ryan P, Valencia J, Cuevas G, Troya J, Ramon C, Rodríguez A, Torres-Macho J, Muñoz-Gómez MJ, Canorea I, Vázquez-Morón S, Resino S. HCV screening based on dried blood samples and linkage to care in people who use drugs: A prospective study. Int J Drug Policy 2021;92:103134. [PMID: 33517130 DOI: 10.1016/j.drugpo.2021.103134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lubkowska A, Pluta W, Strońska A, Lalko A. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection. Int J Mol Sci 2021;22:9366. [PMID: 34502274 DOI: 10.3390/ijms22179366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chevaliez S, Roudot-Thoraval F, Hézode C, Pawlotsky JM, Njouom R. Performance of rapid diagnostic tests for HCV infection in serum or plasma. Future Microbiol 2021;16:713-9. [PMID: 34227402 DOI: 10.2217/fmb-2020-0295] [Reference Citation Analysis]
9 Shahid I, Alzahrani AR, Al-Ghamdi SS, Alanazi IM, Rehman S, Hassan S. Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. Diagnostics (Basel) 2021;11:1253. [PMID: 34359335 DOI: 10.3390/diagnostics11071253] [Reference Citation Analysis]
10 Cunningham EB, Wheeler A, Hajarizadeh B, French CE, Roche R, Marshall AD, Fontaine G, Conway A, Valencia BM, Bajis S, Presseau J, Ward JW, Degenhardt L, Dore GJ, Hickman M, Vickerman P, Grebely J. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022:S2468-1253(21)00471-4. [PMID: 35303490 DOI: 10.1016/S2468-1253(21)00471-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Duchesne L, Hejblum G, Toure Kane NC, Njouom R, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal. Int J Drug Policy 2020;75:102613. [PMID: 31786434 DOI: 10.1016/j.drugpo.2019.102613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Wang H, Zhang Y, Zhou J, Li M, Chen Y, Liu Y, Liu H, Ding P, Liang C, Zhu X, Zhang Y, Xin C, Zhang G, Wang A. Rapid Visual Detection of Hepatitis C Virus Using Reverse Transcription Recombinase-Aided Amplification–Lateral Flow Dipstick. Front Cell Infect Microbiol 2022;12:816238. [DOI: 10.3389/fcimb.2022.816238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Saludes V, Antuori A, Lazarus JV, Folch C, González-Gómez S, González N, Ibáñez N, Colom J, Matas L, Casabona J, Martró E. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain. Int J Drug Policy 2020;80:102734. [PMID: 32470849 DOI: 10.1016/j.drugpo.2020.102734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
14 Yim HJ. Elimination of hepatitis C: What would be the practical approach? Clin Mol Hepatol 2021;27:97-9. [PMID: 33317237 DOI: 10.3350/cmh.2020.0304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Nikiforuk AM, Karim ME, Patrick DM, Jassem AN. Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009-2016). BMC Public Health 2021;21:1388. [PMID: 34256707 DOI: 10.1186/s12889-021-11267-w] [Reference Citation Analysis]
16 Torres-vázquez B, María de Lucas A, García-crespo C, Antonio García-martín J, Fragoso A, Fernández-algar M, Perales C, Domingo E, Moreno M, Briones C. In vitro selection of high affinity DNA and RNA aptamers that detect hepatitis C virus core protein of genotypes 1 to 4 and inhibit virus production in cell culture. Journal of Molecular Biology 2022. [DOI: 10.1016/j.jmb.2022.167501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Ryan P, Valencia J, Cuevas G, Torres-Macho J, Troya J, Pueyo Á, José Muñoz-Gómez M, Muñoz-Rivas N, Vázquez-Morón S, Martinez I, Lazarus JV, Resino S. Detection of active hepatitis C in a single visit and linkage to care among marginalized people using a mobile unit in Madrid, Spain. Int J Drug Policy 2021;96:103424. [PMID: 34429222 DOI: 10.1016/j.drugpo.2021.103424] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lazarus JV, Herranz A, Picchio CA, Villota-Rivas M, Rodríguez A, Alonso JM, Moratinos A, Perrotta A, Tegeo E, Bibiloni F, Buti M, Vilella À. Eliminating hepatitis C on the Balearic Islands, Spain: a protocol for an intervention study to test and link people who use drugs to treatment and care. BMJ Open 2021;11:e053394. [PMID: 34675021 DOI: 10.1136/bmjopen-2021-053394] [Reference Citation Analysis]
19 López-Martínez R, Arias-García A, Rodríguez-Algarra F, Castellote-Bellés L, Rando-Segura A, Tarraso G, Vargas-Accarino E, Montserrat-Lloan I, Blanco-Grau A, Caballero-Garralda A, Ferrer-Costa R, Pumarola-Sunye T, Buti-Ferret M, Esteban-Mur R, Quer J, Casis-Saez E, Rodríguez-Frías F. Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination? J Clin Microbiol 2019;58:e01815-19. [PMID: 31694971 DOI: 10.1128/JCM.01815-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Chevaliez S, Onelia F, Pacenti M, Goldstein E, Galán JC, Martínez-García L, Vilas A, Glass A, Maree L, Krügel M, Ehret R, Knechten H, Braun P, Naeth G, Bonanzinga S, Jackson K, Abravaya K, Dhein J, Huang S, Joseph AM, Lucic D, Marlowe N, Palm MJ, Pfeifer K, Toolsie D, Reinhardt B, Obermeier M, Gunson R. Multicenter clinical evaluation of alinity m HCV assay performance. J Clin Virol 2020;129:104531. [PMID: 32688330 DOI: 10.1016/j.jcv.2020.104531] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
21 Holzmayer V, Taylor R, Kuhns MC, Gawel SH, Ndembi N, Mbanya D, Kaptue L, Rodgers MA, Cloherty G. Evaluation of hepatitis C virus antibody assay using dried blood spot samples. Sci Rep 2022;12:3763. [PMID: 35260691 DOI: 10.1038/s41598-022-07821-0] [Reference Citation Analysis]
22 Butaru AE, Gheonea DI, Rogoveanu I, Diculescu M, Boicea AR, Bunescu M, Streba CT, Oancea CN. Micro-Elimination: Updated Pathway to Global Elimination of Hepatitis C in Small Communities and Industrial Settings during the COVID 19 Pandemic. J Clin Med 2021;10:4976. [PMID: 34768496 DOI: 10.3390/jcm10214976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]